Clinical Trial Detail

NCT ID NCT01275677
Title Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements yes
Sponsors National Cancer Institute (NCI)

breast cancer


Paclitaxel + Trastuzumab + Doxorubicin + Cyclophosphamide

Docetaxel + Cyclophosphamide

Docetaxel + Cyclophosphamide + Trastuzumab

Paclitaxel + Doxorubicin + Cyclophosphamide

Age Groups: adult

Additional content available in CKB BOOST